Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting A Strategic Partner, or a Vendor Looking to You for the Answers? By Krista Armstrong May 29, 2018 Consulting Nostalgia or Shell Shock? Assessing PTSD Is a Challenge by Any Name By Krista Armstrong May 11, 2018 Clinical ResearchPhase 1 - Phase 4 Better Days Ahead? The Emerging State of CNS Drug Development By Krista Armstrong March 8, 2018 Consulting The 3 Ds of a Successful Strategic Sponsor-CRO Partnership By Krista Armstrong December 13, 2017 Consulting 6 Tips for Strategic CRO-Sponsor Partnerships (And Why They’re Important) By Krista Armstrong September 12, 2017 Consulting 4 Obstacles to Collecting Quality Data in Psychiatric Drug Trials By Krista Armstrong June 13, 2017 Previous 1 2 3 Next × ALSO OF INTERESTForging Strong Sponsor-CRO Relationships: Join...Premier Research Strategist to Discuss...Developing Best Practices for Forging...
